Leemor Joshua-Tor

@leemorj

Structural Biologist

Vrijeme pridruživanja: ožujak 2011.

Tweetovi

Blokirali ste korisnika/cu @leemorj

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @leemorj

  1. proslijedio/la je Tweet
    28. sij

    Amaizing, we are talking about modified nucleotides in the bacterial ribosome as seen by cryoEM at overall res of 2.2A. If someone told me this when I started working in ribosomes 10 years ago, I would thought...yeah, sure...

    Poništi
  2. proslijedio/la je Tweet
    24. sij

    Student work was on display tonight at Jack Abrams as the 4th graders showed off their Science Fair projects and our 6th graders shared their creative inventions!

    Poništi
  3. proslijedio/la je Tweet
    22. sij

    It was an absolute pleasure to host United Nations delegates at and showcase some of the exciting science that we do. Many thanks to the lab and especially to H.E. Ms Darja Bavdaz Kuret for making this visit possible

    Poništi
  4. proslijedio/la je Tweet
    20. sij

    📣The new and improved Request a Woman in STEMM is here ✨🍾 Thanks , , for all your hard work making this platform easy to use and beautiful 👩🏻‍💻👩🏽‍💻👩🏿‍💻👩🏼‍💻 Sign up, use it, and help us end

    Poništi
  5. 22. sij

    Had a great day at . Honored to be invited by the undergrads. Had fun talking with faculty and the amazing graduate students and undergrads. Thank you for being a great and gracious host.

    Poništi
  6. proslijedio/la je Tweet
    14. sij
    Prikaži ovu nit
    Poništi
  7. 14. sij

    Congrats to on her thesis defense! Had a wonderful time as her external examiner at and giving a talk and chatting with the awesome scientists there! Thx to all for a lovely visit.

    Poništi
  8. proslijedio/la je Tweet
    14. sij

    Zach Lippman delivering keynote on structural variations in 🌱!

    Poništi
  9. 31. pro 2019.
    Poništi
  10. proslijedio/la je Tweet
    17. pro 2019.

    I’m happy to announce the latest preprint from our lab, this time the work of the talented Dr Shintaro Yamada (山田真太郎). This paper describes the first genome-wide analysis of meiotic double-stand break resection one mice

    Prikaži ovu nit
    Poništi
  11. proslijedio/la je Tweet

    We are delighted to welcome Adrian Krainer from as a newly elected member of the NAM! Congratulations!

    Poništi
  12. proslijedio/la je Tweet
    5. pro 2019.

    Paraspeckles –we've fondly called them "Spector's speckles"– have been a subject of study for 's Archa Fox and CSHL's Dave Spector for years. In this great read, Dr. Fox describes the genesis and importance of this field via 👇

    Poništi
  13. proslijedio/la je Tweet
    4. pro 2019.

    RNA PEOPLE! Pls RT. Thanks to a seed grant, and I are recruiting a postdoc to implement SPLICEOSOME PROFILING in mammalian cells (building on our yeast work: ) Send CV+3 refs to: daniele.canzio@ucsf.edu & hiten.madhani@ucsf.edu.

    Prikaži ovu nit
    Poništi
  14. 5. pro 2019.
    Poništi
  15. proslijedio/la je Tweet
    2. pro 2019.

    Our movable injecting DNA for the 16th annual NIH gingerbread competition!!! was our lead bacteriologist on the project!! – mjesto: NIH Building 10 Mark O. Hatfield Clinical Research Center Atrium

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    4. pro 2019.

    Accepting applications for the 2020 Cryo-EM course at Cold Spring Harbor Lab ! 2 weeks of hands-on training in sample prep, microscope alignment, data collection, and processing - with , , , and invited instructors.

    Poništi
  17. proslijedio/la je Tweet
    26. stu 2019.

    The ASBMB Child Care Grant is a reimbursable allowance of up to $1,000 towards one of the eligible scenarios detailed here: . Remember to apply by 5 p.m. EST tomorrow, Nov. 27!

    Poništi
  18. proslijedio/la je Tweet

    Sad to hear of death of Cyrus Chothia FRS - pioneer of Structural Bioinformatics and a true gentleman

    Poništi
  19. 21. stu 2019.
    Poništi
  20. proslijedio/la je Tweet
    20. stu 2019.

    We are thrilled to share the news that we have received approval for GIVLAARI (givosiran), the second therapeutic from Alnylam approved by the FDA in less than 2 years.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·